These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10650518)

  • 1. [An experimental validation of pharmacological agents to arrest the vestibulo-autonomic syndrome (motion sickness)].
    Shashkov VS; Kotovskaia AR; Orlov OI; Koloteva MI; Shashkov AV; Karsanova SK
    Eksp Klin Farmakol; 1999; 62(6):11-5. PubMed ID: 10650518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prevention and treatment of the symptom complex in motion sickness].
    Esipov IA
    Voen Med Zh; 1973 Feb; 2():69-71. PubMed ID: 4765549
    [No Abstract]   [Full Text] [Related]  

  • 3. [The kinetoses].
    Chüden H
    Med Klin; 1976 Apr; 71(17):689-98. PubMed ID: 775274
    [No Abstract]   [Full Text] [Related]  

  • 4. [Content of biogenic amines and their precursors in human blood during head-down tilt and in taking pharmacological agents to prevent the motion sickness syndrome].
    Davydova NA; Il'ina SL; Sabaev VV
    Kosm Biol Aviakosm Med; 1983; 17(2):53-6. PubMed ID: 6855174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of a method of electrotranquilizing for increasing human vestibular resistance].
    Mel'nik SG; Shakula AV; Ivanov VV
    Voen Med Zh; 1986 Aug; (8):42-5. PubMed ID: 3490051
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention and treatment of space sickness in shuttle-orbiter missions.
    Graybiel A
    Aviat Space Environ Med; 1979 Feb; 50(2):171-6. PubMed ID: 36067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug treatment of motion sickness: scopolamine alone and combined with ephedrine in real and simulated situations.
    Tokola O; Laitinen LA; Aho J; Gothoni G; Vapaatalo H
    Aviat Space Environ Med; 1984 Jul; 55(7):636-41. PubMed ID: 6466260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Model of motion sickness in dogs for assessing the effectiveness of pharmacological substances].
    Radkevich LA
    Kosm Biol Aviakosm Med; 1977; 11(6):50-3. PubMed ID: 22775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chlorpheniramine and ephedrine in combination for motion sickness.
    Buckey JC; Alvarenga DL; MacKenzie TA
    J Vestib Res; 2007; 17(5-6):301-11. PubMed ID: 18626140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of some motion sickness suppressants on static and dynamic tracking performance.
    Schroeder DJ; Collins WE; Elam GW
    Aviat Space Environ Med; 1985 Apr; 56(4):344-50. PubMed ID: 3994616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenytoin for motion sickness: clinical evaluation.
    Knox GW; Woodard D; Chelen W; Ferguson R; Johnson L
    Laryngoscope; 1994 Aug; 104(8 Pt 1):935-9. PubMed ID: 8052077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a new antinauseant drug for the prevention of motion sickness.
    Graybiel A; Knepton J
    Aviat Space Environ Med; 1977 Sep; 48(9):867-71. PubMed ID: 334151
    [No Abstract]   [Full Text] [Related]  

  • 13. [The stabilometric evaluation of resistance to motion sickness in man].
    Govorun MI; Usachev VI; Golovanov AE; Kuznetsov MS
    Vestn Otorinolaringol; 2012; (4):40-1. PubMed ID: 23011368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What you thought you knew about motion sickness isn't necessarily so.
    Cowings PS; Malmstrom FV
    Flying Saf; 1984 Feb; 40(2):12-7. PubMed ID: 11540877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Quantitative evaluation of the clinical manifestations of motion sickness].
    Galle RR
    Kosm Biol Aviakosm Med; 1981; 15(3):72-5. PubMed ID: 7289550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of sodium bicarbonate as a means of treating and preventing motion sickness].
    Barnatskiĭ VN; Brianov II; Volosevich RM; Komarova DP; Kuznetsov AG
    Kosm Biol Med; 1972; 6(6):70-5. PubMed ID: 4543441
    [No Abstract]   [Full Text] [Related]  

  • 17. Promethazine as a motion sickness treatment: impact on human performance and mood states.
    Cowings PS; Toscano WB; DeRoshia C; Miller NE
    Aviat Space Environ Med; 2000 Oct; 71(10):1013-22. PubMed ID: 11051308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of anti-motion sickness drugs in the squirrel monkey.
    Cheung BS; Money KE; Kohl RL; Kinter LB
    J Clin Pharmacol; 1992 Feb; 32(2):163-75. PubMed ID: 1613127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neuroendocrine factors in pathogenesis of motion sickness and the protective effect of drugs].
    Shashkov AV; Karsanova SK; Iasnetsov VV; Tigranian RA; Shashkov VS
    Eksp Klin Farmakol; 2004; 67(2):3-7. PubMed ID: 15188750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An appraisal of the value of vitamin B12 in the prevention of motion sickness.
    Kohl RL; Lacey CL; Homick JL
    Acta Astronaut; 1983 Apr; 10(4):219-24. PubMed ID: 11541554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.